Healthcare provider profile · identity verified

Matthew Winas, D.O.

Internal Medicine · ALLENTOWN, PA · NPI 1194765230

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	783	206
Atorvastatin Calcium	Atorvastatin Calcium	676	194
Levothyroxine Sodium	Levothyroxine Sodium	638	155
Rosuvastatin Calcium	Rosuvastatin Calcium	597	169
Losartan Potassium	Losartan Potassium	596	155
Lisinopril	Lisinopril	342	90
Pantoprazole Sodium	Pantoprazole Sodium	332	99
Gabapentin	Gabapentin	307	86
Simvastatin	Simvastatin	296	74
Metoprolol Succinate	Metoprolol Succinate	279	76
Alprazolam	Alprazolam	245	89
Omeprazole	Omeprazole	239	76
Escitalopram Oxalate	Escitalopram Oxalate	233	65
Famotidine	Famotidine	229	70
Metformin Hcl	Metformin Hcl	200	56
Hydrochlorothiazide	Hydrochlorothiazide	195	59
Eliquis	Apixaban	187	46
Metformin Hcl Er	Metformin Hcl	184	57
Tamsulosin Hcl	Tamsulosin Hcl	182	55
Lorazepam	Lorazepam	178	52
Sertraline Hcl	Sertraline Hcl	153	44
Trazodone Hcl	Trazodone Hcl	152	40
Metoprolol Tartrate	Metoprolol Tartrate	137	43
Synthroid	Levothyroxine Sodium	137	36
Glimepiride	Glimepiride	124	34
Montelukast Sodium	Montelukast Sodium	118	36
Mirtazapine	Mirtazapine	117	41
Allopurinol	Allopurinol	112	28
Furosemide	Furosemide	106	39
Prednisone	Prednisone	105	49
Bupropion Xl	Bupropion Hcl	102	25
Pravastatin Sodium	Pravastatin Sodium	96	24
Olmesartan Medoxomil	Olmesartan Medoxomil	89	22
Propranolol Hcl	Propranolol Hcl	89	31
Doxazosin Mesylate	Doxazosin Mesylate	86	26
Carvedilol	Carvedilol	85	21
Ezetimibe	Ezetimibe	85	27
Celecoxib	Celecoxib	78	22
Albuterol Sulfate Hfa	Albuterol Sulfate	74	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	72	14
Zolpidem Tartrate	Zolpidem Tartrate	71	25
Fluticasone Propionate	Fluticasone Propionate	69	30
Clopidogrel	Clopidogrel Bisulfate	68	21
Duloxetine Hcl	Duloxetine Hcl	65	15
Ozempic	Semaglutide	64	suppressed
Mounjaro	Tirzepatide	59	12
Citalopram Hbr	Citalopram Hydrobromide	58	18
Valsartan	Valsartan	57	17
Nifedipine Er	Nifedipine	53	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	52	suppressed
Spironolactone	Spironolactone	52	16
Atenolol	Atenolol	49	12
Cephalexin	Cephalexin	49	33
Methocarbamol	Methocarbamol	47	18
Azelastine Hcl	Azelastine Hcl	45	21
Buspirone Hcl	Buspirone Hcl	45	suppressed
Jardiance	Empagliflozin	44	12
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Alendronate Sodium	Alendronate Sodium	40	14
Divalproex Sodium	Divalproex Sodium	40	suppressed
Benazepril Hcl	Benazepril Hcl	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	34
Januvia	Sitagliptin Phosphate	38	13
Memantine Hcl	Memantine Hcl	38	suppressed
Tramadol Hcl	Tramadol Hcl	38	12
Nortriptyline Hcl	Nortriptyline Hcl	37	suppressed
Meloxicam	Meloxicam	36	18
Diazepam	Diazepam	35	16
Xarelto	Rivaroxaban	34	11
Enalapril Maleate	Enalapril Maleate	33	suppressed
Ipratropium Bromide	Ipratropium Bromide	33	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	12
Candesartan Cilexetil	Candesartan Cilexetil	32	suppressed
Torsemide	Torsemide	31	11
Ketoconazole	Ketoconazole	30	21
Paxlovid	Nirmatrelvir/Ritonavir	30	29
Potassium Chloride	Potassium Chloride	30	suppressed
Colestipol Hcl	Colestipol Hcl	29	14
Myrbetriq	Mirabegron	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Meclizine Hcl	Meclizine Hcl	28	18
Finasteride	Finasteride	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	14
Acyclovir	Acyclovir	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Amoxicillin	Amoxicillin	21	18
Chlorthalidone	Chlorthalidone	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Methylprednisolone	Methylprednisolone	21	20
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Primidone	Primidone	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Desloratadine	Desloratadine	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Repaglinide	Repaglinide	17	suppressed
Mometasone Furoate	Mometasone Furoate	16	13
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Trospium Chloride	Trospium Chloride	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	12
Eszopiclone	Eszopiclone	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Colesevelam Hcl	Colesevelam Hcl	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Digoxin	Digoxin	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Metolazone	Metolazone	12	suppressed
Nateglinide	Nateglinide	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Rybelsus	Semaglutide	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error